Abstracts accepted for presentations

Below you can find the list of abstracts that have been accepted for oral or poster presentation during ITMIG2023

Oral Presentations

Wednesday, October 4, 2023

17:10-18:00

Title of the abstract and the name of presenter

Imaging Signs Analysis and Clinical Study of Thymic Nodules, Peng Zhang
Quantification of Thymic Epithelial Tumor Volumes through Deep LearningNathan Lay
Clinical Significance of PET/CT SUVmax in Predicting Lymph Node Metastasis of Thymic Epithelial TumorsJianyong Ding
Circulating Exosomal miRNAs as Potential Diagnostic and Prognostic Biomarkers for Thymic Squamous Cell CarcinomaQiangling Sun
High prevalence of Micronodular Thymoma with Lymphoid Stroma as a Thymoma ComponentJan von der Thüsen

Thursday, October 5, 2023

17:10-17:50

Title of the abstract and the name of presenter

Tumor-Related Causes of Death in Patients with Thymic MalignanciesEmily Manin
Phase 2 Clinical Trial of PT-112 in Patients with Thymic Epithelial TumorsMeredith McAdams
Poor Efficacy of Immune Checkpoint Inhibitor Treatment in Advanced Thymic Carcinoma Patients with Liver Metastases: a Multicenter Retrospective StudyYue Hao
Outcomes and Toxicities of Definitive Radiation Therapy for Unresected Thymic MalignanciesSana Raoof
Results of Systemic Therapy and Surgery for Primary Mediastinal SeminomaZhitao Gu

Poster Presentations

Wednesday, October 4, 2023

12:20-13:00

Title of the abstract and the name of presenter

Local Recurrence of Thymoma Following Minimally Invasive Resection: A Retrospective Case SeriesHannah Davis
Surgical Treatment of Thymic Epithelial Tumors: a Single-center Review of Long-term Treatment OutcomesLawek Berzenji
Thymectomy in Thymomatous Generalized Myasthenia Gravis: an Analysis of Prognosis and Risk FactorsJinwei Zhang
Atypical Morphologies of Thymic Hyperplasia on CT and MRITetsuro Araki
The Role of 18F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic LesionsPaolo Mendogni
Challenges in Thymic Imaging, Maximiliano Klug
Incidence, Pathology and Characteristics of Danish TET PatientsTine Oestergaard
Asymptomatic Lipofibroadenoma in a 17-year old MaleJan von der Thüsen
Evaluation of Potential Therapeutic Immunohistochemical Targets with Experimental or FDA-approved Therapies in Thymic Epithelial Tumor MicroarraysFatemeh Ardeshir Larijani
Basaloid Carcinoma of the Thymus: Experience of the RYTHMIC Network over an 8-year PeriodNicolas Piton
Genomic Profiling and Possible Therapy Targets of Thymic Carcinoma of Chinese Based on Whole-Exome Sequencing, Juan Li
Case Report: Primary Adenocarcinoma NOS of the Thymus and Cytological FeaturesJonathan Willner
The Dutch ‘International’ Thymoma Panel, the First 11 Years ExperienceJan von der Thüsen
Establishing a Thymic Network in the United Kingdom (UK)David Gilligan
Female Patients Developing B type Thymoma after Breast Implantation: a Report of 6 CasesChanglu Wang
Racial and Ethnic Differences in Thymic Epithelial Tumors: a Single-institution Retrospective Analysis, Brice Wuthrich

Thursday, October 5, 2023

12:10-13:00

Title of the abstract and the name of presenter

In vitro Study on Atg12-Mediated Autophagy in Dendritic Cells Promotes Myasthenia Gravis Development in ThymomaPeng Zhang
Spatial Proteomic Analysis of the Human Thymic Microenvironment Shaping T cell DevelopmentKirolous Hanna
Immunocytometric Analysis of Patients with Thymic Epithelial Tumors Revealed that COVID-19 Vaccine Booster Strongly Enhanced the Immune ResponseErica Pietroluongo
A Study of the Association Between Thymic Malignancy Histology and Autoimmune Paraneoplastic Syndromes and Opportunistic InfectionsMaria Isabel Leite
Occurrence and Severity of COVID-19 in Patients Affected by Thymic Epithelial Tumors with or without Good’s Syndrome: a Single Centre Experience, Erica Pietroluongo
The Potential Role of Innate Lymphoid Cells in Thymic Epithelial Tumors, Erica Pietroluongo
Prednisone as Neoadjuvant Therapy in ThymomasDiana Bacchin
Unexpected Long-lasting Control of Thymic Carcinoma Treated with anti-PD1 and Oral Etoposide: a Real Life Experience of Combination TherapyGiovannella Palmieri
A Case of Myasthenia Gravis, Pure Red Cell Aplasia and Thymoma, but Not in the Order one Might ExpectMohammad Ashraghi
Reduction of Thymoma After Glucocorticoid Therapy in Autoimmune Diseases: Case Reports and Literature ReviewYuan Chen
Bone Marrow Dyscrasias in AIRE Deficiency: Lessons from Thymoma and APECEDLaercio DaSilva
An Evaluation of Cisplatin, Doxorubicin and Cyclophosphamide (PAC) Versus Other Regimens for Patients with Unresectable or Metastatic Thymic CarcinomaBrice Wuthrich
Thymoma and T- cell Lymphoblastic Leukemia/Lymphoma: Where is the Connection? Lizbeth Rondon Rueda
Anti-Angiogenesis Therapy in Patients of Thymic Malignancies with Hepatic MetastasisXiaomin Niu
Hepatoid Thymic Carcinoma: a Case Report of Response to Immune Checkpoint InhibitorSiddhartha Devarakonda
Comorbidities in Danish Patients with Thymic Epithelial TumorsTine Oestergaard
The Correlation Analysis Of Survival Benefit Of Postoperative Radiotherapy For Aggressive Thymic Epithelial Tumors, Peng Zhang
Recommendations for Post-Operative Radiotherapy after Complete Resection of Thymoma - a French DELPHI Consensus Initiative, Clemence Basse


A reward for the first author of the best abstract!

100% discount of a registration fee for the next ITMIG2024 Annual Meeting!